The development of New Zealand's Needle and Syringe Exchange Programme

International Journal of Drug Policy

Volumn 15, Issue 3, 2004, Pages 202-206

  Kemp, Robert ^a   Aitken, Campbell ^b  

^a QUEENSLAND HEALTH   (Australia)

^b BURNET INSTITUTE   (Australia)

Author keywords

Development; IDU peers; Injection drug use; Needle and syringe programme; New Zealand

Indexed keywords

BUPRENORPHINE; CODEINE; DIAMORPHINE; ILLICIT DRUG; MORPHINE; MORPHINE SULFATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUSTRALIA; DRUG ABUSE; EVOLUTION; GOVERNMENT; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HISTORY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; NEEDLE; NEW ZEALAND; POLITICS; PRIORITY JOURNAL; REVIEW; SYRINGE;

EID: 2642569155     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2004.01.002     Document Type: Article

References (18)

1. Aitken, C. K. (2002). New Zealand Needle and Syringe Exchange Programme review: Final report. Wellington: New Zealand Ministry of Health.
2. Board of Health. (1970). Drug Dependency and Drug Abuse in New Zealand (Report Series #14). Wellington: Board of Health.
3. Brunton C., Kemp R., Raynel P., Harte D., Baker M. Cumulative incidence of hepatitis C seroconversion in a cohort of seronegative injecting drug users. New Zealand Medical Journal. 113:2000;98-101
4. Crofts N., Aitken C.K. Incidence of and risk behaviours for blood-borne viruses in a cohort of injecting drug users in Victoria, 1990-95. Medical Journal of Australia. 167:1997;17-20
5. Davis, P., & Lichtenstein, B. (1996). In P. Davis (Ed.), AIDS, sexuality and the social order in New Zealand. Intimate details and vital statistics. Auckland: Auckland University Press.
6. Hannifin J. Methadone maintenance treatment in New Zealand - Back to the future? Journal of Maintenance in the Addictions. 1(2):1997;69-80
7. Kaplan E.H., Heimer R. A circulation theory of needle exchange. AIDS. 8(5):1994;567-574
8. Kemp, R. (1993). Pilot proposal: National Needle Exchange (& Bleach) Programme. Discussion paper prepared for the New Zealand AIDS Foundation, Wellington. Unpublished.
9. Kemp, R. (1996). In P. Davis (Ed.), From a bang to a whimper: Policy responses to injecting drug use and viral infection. Intimate details and vital statistics. Auckland: Auckland University Press.
10. Kemp R., MacDonald M. Injecting drug users have high rates of hepatitis C but HIV infection remains uncommon. New Zealand Public Health Report. 6(3):1999;17-19
11. Kemp R., Miller J., Lungley S., Baker M. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations. New Zealand Medical Journal. 111:1998;50-53
12. Lindberg, W., & McMorland, J. (1996). In P. Davis (Ed.), From grassroots to business suits: The gay community response to AIDS. Intimate details and vital statistics. Auckland: Auckland University Press.
13. McNicholas, A., Garret, N., & Baker, M. (1996). Utilisation of the Needle Exchange Programme in New Zealand (update: June 1996). Report to the (NZ) Ministry of Health, Wellington. Institute of Environmental Science and Research.
14. Needle Exchange New Zealand (NENZ). (2000, March). Performance report to the Health Funding Authority.
15. Nesdale, A., Baker, M., Gane, E., Kemp, R., Brunton, C., Law, M., et al. (2000). Hepatitis C infection in New Zealand: Estimating the current and future prevalence and impact. Report to the (NZ) Ministry of Health, Wellington. Institute of Environmental Science and Research.
16. Shetland, J. (1987). A national survey of New Zealanders' knowledge, attitudes and behaviour relating to AIDS. Report to the New Zealand Department of Health, Wellington.
17. Statistics New Zealand. (2003). Available from: http://www.stats.govt.nz
18. Walker, N., Baker, M. (1994). Utilisation of the Needle Exchange Programme in New Zealand (1988-1993). Report to the New Zealand Ministry of Health, Wellington. Institute of Environmental Science and Research.